Home » Topics » Regulatory » Patents

Patents
RSS

H. Lundbeck describes PDE1 inhibitors

Nov. 16, 2016

ImmunoMet Therapeutics discloses OXPHOX inhibitors

Nov. 16, 2016

Arena Pharmaceuticals patents 5-HT2C receptor agonists

Nov. 16, 2016

Vallaurix presents MC1 receptor agonists

Nov. 15, 2016

Novartis develops FXR agonists

Nov. 15, 2016

Xiamen University describes ALK and/or c-Met inhibitors

Nov. 15, 2016

Katholieke Universiteit Leuven discloses PMDT nucleoside phosphonates

Nov. 15, 2016

Texas A&M University patents antimycobacterial agents

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

The Vanderbilt University discloses M1 receptor PAMs

Nov. 14, 2016

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...